Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors
Charles Erlichman, Manuel Hidalgo, Joseph P. Boni, Patricia Martins, Susan E. Quinn, Charles Zacharchuk, Peter Amorusi, Alex A. Adjei, Eric K. Rowinsky
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors'. Together they form a unique fingerprint.